Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy

Published:2022-08 Issue:5 Volume:17 Page:641-652
ISSN:1818-0876
Container-title:Asian Journal of Pharmaceutical Sciences
language:en
Short-container-title:Asian Journal of Pharmaceutical Sciences

Author:

Ju Hyemin^ORCID,Kim Dongyoon^ORCID,Oh Yu-Kyoung

Funder

Ministry of Science, ICT and Future Planning

Ministry of Health and Welfare

National Research Foundation of Korea

Korea Ministry of Science and ICT

Ministry of Education

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference37 articles.

1. Nano delivery systems and cancer immunotherapy;Le;J Pharm Investig,2018

2. The future of cancer immunotherapy: microenvironment-targeting combinations;Murciano-Goroff;Cell Res,2020

3. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges;Martin;Nat Rev Clin Oncol,2020

4. Top 10 challenges in cancer immunotherapy;Hegde;Immunity,2020

5. De-novo and acquired resistance to immune checkpoint targeting;Syn;Lancet Oncol,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for organic nanoparticles delivering CRISPR/Cas9 for cancer therapy: Challenges and breakthroughs;Materials & Design;2024-08

2. Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing;Small Science;2024-07-25

3. Intravenous delivery of STING agonists using acid-sensitive polycationic polymer-modified lipid nanoparticles for enhanced tumor immunotherapy;Acta Pharmaceutica Sinica B;2024-06

4. The landscape of extracellular vesicles combined with intranasal delivery towards brain diseases;Nano Today;2024-04

5. The ethically significant difference between dual use and slippery slope arguments, in relation to CRISPR-Cas9: philosophical considerations and ethical challenges;Research Ethics;2024-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3